BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20039321)

  • 1. Association between antibiotic use and risk of prostate cancer.
    Tamim HM; Hajeer AH; Boivin JF; Collet JP
    Int J Cancer; 2010 Aug; 127(4):952-60. PubMed ID: 20039321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic use and risk of gynecological cancer.
    Tamim HM; Musallam KM; Al Kadri HM; Boivin JF; Collet JP
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):388-93. PubMed ID: 21741150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of breast cancer in relation to antibiotic use.
    Tamim HM; Hanley JA; Hajeer AH; Boivin JF; Collet JP
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):144-50. PubMed ID: 17943999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants and risk of prostate cancer: a nested case-control study.
    Tamim HM; Mahmud S; Hanley JA; Boivin JF; Stang MR; Collet JP
    Prostate Cancer Prostatic Dis; 2008; 11(1):53-60. PubMed ID: 17684479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent antibiotic exposure may promote cancer formation--Another step in understanding the role of the human microbiota?
    Boursi B; Mamtani R; Haynes K; Yang YX
    Eur J Cancer; 2015 Nov; 51(17):2655-64. PubMed ID: 26338196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer.
    Perron L; Bairati I; Moore L; Meyer F
    Int J Cancer; 2003 Sep; 106(3):409-15. PubMed ID: 12845682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of prostate cancer death in long-term users of warfarin: a population-based case-control study.
    Tagalakis V; Tamim H; Blostein M; Hanley JA; Kahn SR
    Cancer Causes Control; 2013 Jun; 24(6):1079-85. PubMed ID: 23494728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validating a method that deals with missing drug information in the Saskatchewan Drug Plan database.
    Tamim HM; Tagalakis V
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):140-6. PubMed ID: 19090502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin use and prostate cancer risk.
    Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
    Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of warfarin use on clinical stage and histological grade of prostate cancer.
    Tagalakis V; Tamim H
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):436-9. PubMed ID: 20437456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated With the Prevalence of Prostate Cancer in Rural Saskatchewan: The Saskatchewan Rural Health Study.
    Sharma M; Lawson JA; Kanthan R; Karunanayake C; Hagel L; Rennie D; Dosman JA; Pahwa P;
    J Rural Health; 2016; 32(2):125-35. PubMed ID: 26265246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies.
    Zhang F; Yang Y; Skrip L; Hu D; Wang Y; Wong C; Qiu J; Lei H
    Acta Diabetol; 2012 Dec; 49 Suppl 1():S235-46. PubMed ID: 23124624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in case mix and treatment patterns in prostate cancer in Saskatchewan during the prostate specific antigen testing era.
    Tonita JM; Skarsgard D; Muhajarine N
    Cancer Causes Control; 2009 Mar; 20(2):201-9. PubMed ID: 18825504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidiabetic medication and prostate cancer risk: a population-based case-control study.
    Murtola TJ; Tammela TL; Lahtela J; Auvinen A
    Am J Epidemiol; 2008 Oct; 168(8):925-31. PubMed ID: 18700234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between antihypertensive drug use and incidence of prostate cancer in Finland: a population-based case-control study.
    Kemppainen KJ; Tammela TL; Auvinen A; Murtola TJ
    Cancer Causes Control; 2011 Oct; 22(10):1445-52. PubMed ID: 21769492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal propensity for infections and risk of childhood asthma: a registry-based cohort study.
    Stokholm J; Sevelsted A; Bønnelykke K; Bisgaard H
    Lancet Respir Med; 2014 Aug; 2(8):631-7. PubMed ID: 25066330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sun exposure may increase risk of prostate cancer in the high UV environment of New South Wales, Australia: a case-control study.
    Nair-Shalliker V; Smith DP; Egger S; Hughes AM; Kaldor JM; Clements M; Kricker A; Armstrong BK
    Int J Cancer; 2012 Sep; 131(5):E726-32. PubMed ID: 22173996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.